Association between Thr21Met and Ser89Asn polymorphisms of the urotensin II gene and systemic sclerosis

Journal of Rheumatology

Volumn 39, Issue 1, 2012, Pages 106-111

  Pehlivan, Yavuz ^a   Gogebakan, Bulent ^a   Oztuzcu, Serdar ^a   Ozgen, Metin ^b   Cetin, Goz̈de Yildirim ^c   Bayraktar, Recep ^a   Cengiz, Beyhan ^a   Kisacik, Bunyamin ^a   Koca, Suleyman Serdar ^b   Donmez, Salim ^d   Sayarlioglu, Mehmet ^c   Demiryurek, Abdullah T ^a   Onat, Ahmet Mesut ^a  

^a GAZIANTEP UNIVERSITY   (Turkey)

^b FIRAT UNIVERSITY   (Turkey)

^c KAHRAMANMARAS SUTCU IMAM UNIVERSITY   (Turkey)

^d TRAKYA UNIVERSITY   (Turkey)

Author keywords

Systemic sclerosis; Urotensin II; Urotensin II gene

Indexed keywords

CENTROMERE ANTIBODY; DNA TOPOISOMERASE ANTIBODY; ENZYME ANTIBODY; METHIONINE; SERINE; THREONINE; UNCLASSIFIED DRUG;

ADULT; ANTIBODY DETECTION; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FINGER MALFORMATION; GENE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC SCLEROSIS; TURKEY (REPUBLIC); UROTENSIN II GENE;

ADULT; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SCLERODERMA, SYSTEMIC; SERINE; THREONINE; TURKEY; UROTENSINS;

EID: 84855406054     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.110509     Document Type: Article

References (27)

1. Agarwal SK. The genetics of systemic sclerosis. Discov Med 2010;10:134-43.
2. Martin J, Fonseca C. The genetics of scleroderma. Curr Rheumatol Rep 2011;13:13-20.
3. Mahoney WM Jr, Fleming JN, Schwartz SM. A unifying hypothesis for scleroderma: identifying a target cell for scleroderma. Curr Rheumatol Rep 2011;13:28-36.
4. Hunzelmann N, Krieg T. Scleroderma: from pathophysiology to novel therapeutic approaches. Exp Dermatol 2010;19:393-400.
5. Ross B, McKendy K, Giaid A. Role of urotensin II in health and disease. Am J Physiol Regul Integr Comp Physiol 2010;298:1156-72.
6. Vancheeswaran R, Magoulas T, Efrat G, Wheeler-Jones C, Olsen I, Penny R, et al. Circulating endothelin-1 levels in systemic sclerosis subsets: A marker of fibrosis or vascular dysfunction? J Rheumatol 1994;21:1838-44. (Pubitemid 24312644)
7. Maguire JJ, Kuc RE, Davenport AP. Orphan-receptor ligand human urotensin II: Receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1. Br J Pharmacol 2000;131:441-6.
8. Bousette N, Giaid A. Urotensin-II and cardiovascular diseases. Curr Hypertens Rep 2006;8:479-83. (Pubitemid 44842774)
9. Tian L, Li C, Qi J, Fu P, Yu X, Li X, et al. Diabetes-induced upregulation of urotensin II and its receptor plays an important role in TGF-beta-1-mediated renal fibrosis and dysfunction. Am J Physiol Endocrinol Metab 2008;295:1234-42.
10. Kemp W, Kompa A, Phrommintikul A, Herath C, Zhiyuan J, Angus P, et al. Urotensin II modulates hepatic fibrosis and portal hemodynamic alterations in rats. Am J Physiol Gastrointest Liver Physiol 2009;297:762-7.
11. Tran L, Kompa AR, Kemp W, Phrommintikul A, Wang BH, Krum H. Chronic urotensin-II infusion induces diastolic dysfunction and enhances collagen production in rats. Am J Physiol Heart Circ Physiol 2010;298:608-13.
12. Pehlivan Y, Onat AM, Comez G, Babacan T. Urotensin-II in systemic sclerosis: A new peptide in pathogenesis. Clin Rheum 2011;30:837-42.
13. Wenyi Z, Suzuki S, Hirai M, Hinokio Y, Tanizawa Y, Matsutani A, et al. Role of urotensin II gene in genetic susceptibility to Type 2 diabetes mellitus in Japanese subjects. Diabetologia 2003;46:972-6. (Pubitemid 36961321)
14. Suzuki S, Wenyi Z, Hirai M, Hinokio Y, Suzuki C, Yamada T, et al. Genetic variations at urotensin II and urotensin II receptor genes and risk of type 2 diabetes mellitus in Japanese. Peptides 2004;25:1803-8. (Pubitemid 39346224)
15. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980;23:581-90.
16. Galiè N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009;30:2493-537.
17. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acids Res 1988;16:1215.
18. Li Z, Zhang Z, He Z, Tang W, Li T, Zeng Z, et al. A partition-ligation- combination-subdivision EM algorithm for haplotype inference with multiallelic markers: Update of the SHEsis (http://analysis.bio-x.cn). Cell Res 2009;19:519-23.
19. Varga J, Abraham D. Systemic sclerosis: A prototypic multisystem fibrotic disorder. J Clin Invest 2007;117:557-67. (Pubitemid 46348510)
20. Manetti M, Guiducci S, Ibba-Manneschi L, Matucci-Cerinic M. Mechanisms in the loss of capillaries in systemic sclerosis: Angiogenesis versus vasculogenesis. J Cell Mol Med 2010;14:1241-54.
21. Agarwal SK, Tan FK, Arnett FC. Genetics and genomic studies in scleroderma (systemic sclerosis). Rheum Dis Clin North Am 2008;34:17-40. (Pubitemid 351337628)
22. Agarwal SK, Reveille JD. The genetics of scleroderma (systemic sclerosis). Curr Opin Rheumatol 2010;22:133-8.
23. Zhu YC, Zhu YZ, Moore PK. The role of urotensin II in cardiovascular and renal physiology and diseases. Br J Pharmacol 2006;148:884-901. (Pubitemid 44543606)
24. Elshourbagy NA, Douglas SA, Shabon U, Harrison S, Duddy G, Sechler JL, et al. Molecular and pharmacological characterization of genes encoding urotensin-II peptides and their cognate G-protein-coupled receptors from the mouse and monkey. Br J Pharmacol 2002;136:9-22. (Pubitemid 34499311)
25. Ong KL, Wong LYF, Man YB, Leung RYH, Song YQ, Lam KSL, et al. Haplotypes in the urotensin II gene and urotensin II receptor gene are associated with insulin resistance and impaired glucose tolerance. Peptides 2006;27:1659-67. (Pubitemid 43884768)
26. Jiang Z, Michal JJ, Tobey DJ, Wang Z, MacNeil MD, Magnusan NS. Comparative understanding of UTS2 and UTS2R gene for their involvement in type 2 diabetes mellitus. Int J Biol Sci 2008;4:96-102. (Pubitemid 351872039)
27. Yi L, Gu YH, Wang XL, An LZ, Xie XD, Shao W, et al. Association of ACE, ACE2 and UTS2 polymorphisms with essential hypertension in Han and Dongxiang populations from North-western China. J Int Med Res 2006;34:272-83. (Pubitemid 44057270)